Durvalumab becomes first immunotherapy recommended for LS-SCLC patients in England and Wales More: Imfinzi approved for NHS use in limited-stage small cell lung cancer Source: News
read more
MHRA greenlights oral therapy for patients aged 12 and over with grade 2 astrocytoma More: Vorasidenib approved in UK for treating IDH-mutant brain tumours Source: News
read moreLast week, on the same day the Trump administration laid out its plan to rein in direct-to-consumer drug advertising, the FDA sent out its first untitled letter in months, this one taking issue with a commercial for AstraZeneca’s self-administered FluMist
read moreThe FDA reprimand focuses on five manufacturing deficiencies observed during the inspection, which took place from Sept. 4 to Sept. 12. The company didn’t detail the infractions in its filing, saying only that it plans to address the issues “within
read moreEli Lilly has revealed the location of the first of four large-scale manufacturing facilities that it plans to build in the U.S. The company has selected Goochland County, Virginia, as the site of a $5 billion plant, which will produce
read moreAfter HHS secretary Robert F. Kennedy Jr. overhauled the CDC’s vaccine advisory panel over the summer, he’s adding to the group’s lineup with five new members. More: HHS taps 5 new members for CDC vaccine panel ahead of this week's
read more© 1994 - 2026 B.M. Pharmaceuticals